{"analyses":[{"ciNumSides":"TWO_SIDED","ciPctValue":"95","groupDescription":"The event-free survival distributions of patients randomized to Regimen A - Single HST (CEM) and randomized to Regimen B - Tandem HST (CEM) were compared using the log-rank test.","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY_OR_OTHER_LEGACY","pValue":"0.0082","paramType":"Log Rank Test Statistic","paramValue":"6.9883","statisticalMethod":"Log Rank"}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"41.1","upperLimit":"56.5","value":"48.8"},{"groupId":"OG001","lowerLimit":"53.8","upperLimit":"69.8","value":"61.8"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"179"},{"groupId":"OG001","value":"176"}],"units":"Participants"}],"description":"Comparison of EFS curves, starting from the time of randomization, by treatment group (single CEM vs. tandem CEM)","dispersionType":"95% Confidence Interval","groups":[{"description":"Induction therapy + single myeloablative consolidation","id":"OG000","title":"Single HST (CEM)"},{"description":"Induction therapy + tandem myeloablative consolidation","id":"OG001","title":"Tandem HST (CEM), Randomly Assigned"}],"paramType":"NUMBER","populationDescription":"All eligible, randomized patients.","reportingStatus":"POSTED","timeFrame":"Three years, from time of randomization","title":"Event-free Survival Rate","type":"PRIMARY","unitOfMeasure":"percent probability"}